Looking to establish presence in China: Lupin Medical Dialogues Bureau15 Oct 2018 2:07 PM ISTMumbai: Drug major Lupin is looking to establish presence in China as part of its strategy to strengthen its markets in the Asia Pacific region, a...
Dr Reddy's Laboratories recalls 35,000 tubes of skin infection cream from US Medical Dialogues Bureau15 Oct 2018 2:05 PM ISTNew Delhi: Dr Reddy's Laboratories' US arm is recalling over 35,000 tubes of Nystatin and Triamcinolone Acetonide cream on account of failed...
Diagnostic startup Healthians launches operations in Punjab Medical Dialogues Bureau15 Oct 2018 9:56 AM ISTChandigarh: Online diagnostic startup Healthians Friday announced the launch of its operations in Punjab. Healthians will be making an investment of...
Embattled Chinese drug maker to get 43 million dollars in government support Medical Dialogues Bureau15 Oct 2018 9:04 AM ISTSHANGHAI: - A Chinese city government has given 300 million yuan ($43 million) to drug maker Zhejiang Huahai Pharmaceuticals, the company said, after...
Themis Bioscience Announces Exclusive Licensing Agreement with Max-Planck-Innovation for Oncolytic Virotherapies Medical Dialogues Bureau14 Oct 2018 10:16 AM ISTNew Delhi: Themis announced that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max...
Pfizer announces $3 million grant for ASPIRE Breast Cancer Research Medical Dialogues Bureau14 Oct 2018 9:58 AM ISTNew Delhi: Pfizer Inc. has recently announced the recipients of the Advancing Science through Pfizer Investigator Research Exchange (ASPIRE) Breast...
Bristol-Myers to invest in Compugen, collaborate in clinical trials Medical Dialogues Bureau14 Oct 2018 9:16 AM ISTTEL AVIV - Bristol-Myers Squibb Co and Israel’s Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid...
Lundbeck gets DCGI nod for Brintellix antidepressant, launches in India Medical Dialogues Bureau13 Oct 2018 12:46 PM ISTBrintellix, is a novel multimodal antidepressant, which has been specifically designed to inhibit serotonin reuptake and modulate serotonergic...
Zydus Cadila gets tentative USFDA nod for Linagliptin and Metformin Hydrochloride tablets Medical Dialogues Bureau13 Oct 2018 12:26 PM ISTNew Delhi: Drug firm Zydus Cadila Friday said it has received tentative approval from the US health regulator to market Linagliptin and Metformin...
Abbvie settles Humira patent disputes with Novartis unit Medical Dialogues Bureau13 Oct 2018 9:16 AM ISTAbbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat...
Amway appoints Milind Pant as CEO Medical Dialogues Bureau13 Oct 2018 9:00 AM ISTMichigan: Direct selling major Amway Friday announced appointment of Milind Pant, first Indian and non-family individual, as its Chief Executive...
UP to open 6 pharma parks; gets Rs 5,000-6,000 Crore commitment Medical Dialogues Bureau12 Oct 2018 2:24 PM ISTThe Uttar Pradesh government is planning to open six pharma parks across the state and has received an investment commitment of about Rs 5,000-6,000...
